Immediate Outcomes of Surgical Treatment for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Author:

Giller D. B.1ORCID,Saenko S. S.2,Gerasimov A. N.3ORCID,Shcherbakova G. V.1ORCID,Popova A. A.1ORCID,Basangova V. A.1ORCID,Ilyukhin A. N.1ORCID,Kesaev O. Sh.1ORCID,Bagdasaryan E. A.1ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University

2. Regional Clinical Center of Phthisiopulmonology

3. Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Abstract

Objective: To study and compare surgical risks and immediate effectiveness of surgical treatment in patients with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).Materials and methods: We examined immediate treatment outcomes of 1180 patients who underwent surgery for destructive MDRTB, pre-XDR-TB, and XDR-TB between 2011 and 2023. The patients were grouped: group 1 for patients with MDR-TB (744 cases) and group 2 for patients with pre-XDR-TB and XDR-TB (436 cases). Moreover, patients were further subdivided based on the extent of surgery.Results: The complete clinical response, ie, cavity closure and elimination of bacilli (CV-, MBT-), was achieved in all 405 patients who underwent radical surgery, in 673 (97.1%) of 694 patients who underwent semiradical surgery, and only in 10 (12.3%) of 81 patients who underwent palliative surgery.Conclusions: The immediate outcomes of surgical treatment for MDR-TB were superior in all parameters compared with those for pre-XDR-TB and XDR-TB; however, we found no significant differences when we evaluated treatment effectiveness in patients who underwent radical and semiradical surgery. 

Publisher

Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1

Reference12 articles.

1. World Health Organization. Global Tuberculosis Report 2015. World Health Organization; 2015.

2. Giller DB, Giller BD, Giller GV, et al. Treatment of pulmonary tuberculosis: past and present. Eur J Cardiothorac Surg. 2018;53(5):967–972. https://doi.org/10.1093/ejcts/ezx447

3. Tereshkovych OV. Results of surgical treatment of patients with multidrug-resistant lung tuberculosis and extensively drugresistant pulmonary tuberculosis. Colloquium-journal. 2020;(15– 1):15–18. (In Russ.).

4. Porkhanov VA, Marchenko LG, Polyakov IS. Surgical treatment of bilateral forms of pulmonary tuberculosis. Probl Tuberk. 2002;79(4):22–25. (In Russ.).

5. Garifullin ZR, Aminev KhK. Efficiency of surgical treatment in patients with drug-resistant pulmonary tuberculosis in relation to the course of a disease. Tuberk Biolezni Legkih. 2009;(7):41–46. (In Russ.). PMID: 19697856.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3